Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ISRGNYSE:JNJ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$494.61-2.5%$550.11$364.17▼$616.00$176.17B1.431.53 million shs2.73 million shsJNJJohnson & Johnson$159.90+2.9%$159.36$140.68▼$169.99$385.33B0.477.76 million shs13.24 million shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical+2.15%-0.39%-10.57%-3.24%+32.61%JNJJohnson & Johnson+1.41%-3.86%-6.98%+7.91%-1.47%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationISRGIntuitive Surgical4.5432 of 5 stars3.33.00.04.03.52.51.9JNJJohnson & Johnson4.3132 of 5 stars2.33.04.23.93.22.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceISRGIntuitive Surgical 2.67Moderate Buy$611.8623.70% UpsideJNJJohnson & Johnson 2.56Moderate Buy$171.337.15% UpsideCurrent Analyst Ratings BreakdownLatest JNJ and ISRG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/2/2025JNJJohnson & JohnsonRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.004/2/2025JNJJohnson & JohnsonGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral3/18/2025ISRGIntuitive SurgicalRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$707.00 ➝ $600.003/17/2025ISRGIntuitive SurgicalErste Group BankSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold3/17/2025ISRGIntuitive SurgicalTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$666.00 ➝ $605.003/10/2025JNJJohnson & JohnsonGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral3/5/2025JNJJohnson & JohnsonBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$159.00 ➝ $171.002/19/2025JNJJohnson & JohnsonRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.002/3/2025JNJJohnson & JohnsonGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$162.00 ➝ $166.001/28/2025JNJJohnson & JohnsonBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$159.00 ➝ $166.001/27/2025ISRGIntuitive SurgicalCICC ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$550.00(Data available from 4/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookISRGIntuitive Surgical$8.35B21.09$6.51 per share75.93$46.41 per share10.66JNJJohnson & Johnson$88.82B4.34$13.14 per share12.17$29.69 per share5.39Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateISRGIntuitive Surgical$2.32B$6.4177.1664.825.8527.81%14.55%12.88%4/22/2025 (Estimated)JNJJohnson & Johnson$14.07B$6.6524.0414.442.5618.20%34.24%13.63%4/15/2025 (Estimated)Latest JNJ and ISRG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/22/2025N/AISRGIntuitive Surgical$1.71N/AN/AN/A$2.19 billionN/A4/15/2025N/AJNJJohnson & Johnson$2.59N/AN/AN/A$21.65 billionN/A1/22/2025Q4 2024JNJJohnson & Johnson$1.99$2.04+$0.05$1.41$22.44 billion$22.52 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthISRGIntuitive SurgicalN/AN/AN/AN/AN/AJNJJohnson & Johnson$4.963.10%+5.43%74.59%63 YearsCompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioISRGIntuitive SurgicalN/A4.073.22JNJJohnson & Johnson0.431.110.86Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipISRGIntuitive Surgical83.64%JNJJohnson & Johnson69.55%Insider OwnershipCompanyInsider OwnershipISRGIntuitive Surgical0.70%JNJJohnson & Johnson0.16%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableISRGIntuitive Surgical12,100356.18 million352.97 millionOptionableJNJJohnson & Johnson152,7002.41 billion2.40 billionOptionableJNJ and ISRG HeadlinesRecent News About These CompaniesJohnson & Johnson Faces Bankruptcy Plan RejectionApril 3 at 5:11 PM | tipranks.comJNJ vs. PFE: Which Drug Giant is a Better Buy Now?April 3 at 11:00 AM | zacks.comClimber Capital SA Makes New $303,000 Investment in Johnson & Johnson (NYSE:JNJ)April 3 at 7:01 AM | marketbeat.comPitcairn Co. Sells 5,256 Shares of Johnson & Johnson (NYSE:JNJ)April 3 at 6:39 AM | marketbeat.comGrant Private Wealth Management Inc Invests $306,000 in Johnson & Johnson (NYSE:JNJ)April 3 at 6:31 AM | marketbeat.comSelway Asset Management Has $271,000 Stock Holdings in Johnson & Johnson (NYSE:JNJ)April 3 at 6:30 AM | marketbeat.comWorld Investment Advisors Buys 12,187 Shares of Johnson & Johnson (NYSE:JNJ)April 3 at 6:20 AM | marketbeat.comVenture Visionary Partners LLC Has $54.88 Million Stock Holdings in Johnson & Johnson (NYSE:JNJ)April 3 at 5:56 AM | marketbeat.comDisciplined Investors L.L.C. Purchases New Holdings in Johnson & Johnson (NYSE:JNJ)April 3 at 5:56 AM | marketbeat.comWhy Johnson & Johnson Stock Is Sinking TodayApril 3 at 2:40 AM | finance.yahoo.comJohnson & Johnson (JNJ): Among the Best Healthcare Stocks to Buy According to BillionairesApril 2 at 9:29 PM | finance.yahoo.comJudge rejects Johnson & Johnson's talc settlementApril 2 at 7:31 PM | finance.yahoo.comJohnson & Johnson has positive dual-energy ablation dataApril 2 at 7:11 PM | massdevice.comJohnson & Johnson talc litigation ‘hit another snag,’ says CitiApril 2 at 7:11 PM | markets.businessinsider.comWatch These Johnson & Johnson Levels as Stock Plunges After Judge Rejects Talc SettlementApril 2 at 7:11 PM | msn.comJohnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to ConsiderApril 2 at 6:50 PM | zacks.comWorried About the Economy? 2 No-Brainer Buys to Shield Your Portfolio.April 2 at 6:15 PM | fool.comIntra-Cellular Therapies Completes Merger with Johnson & JohnsonApril 2 at 4:55 PM | tipranks.comJohnson & Johnson (NYSE:JNJ) Trading 1.2% Higher - Here's What HappenedApril 2 at 1:19 PM | marketbeat.comStock Of The Day: Will Johnson & Johnson Rally? The Sell-Off May Have EndedApril 2 at 1:10 PM | benzinga.comJohnson & Johnson's (JNJ) Outperform Rating Reaffirmed at Royal Bank of CanadaApril 2 at 12:22 PM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWarren Buffett Swaps VOO for This Reliable Dividend StockBy Sarah Horvath | March 7, 2025View Warren Buffett Swaps VOO for This Reliable Dividend StockNVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a BuyBy Thomas Hughes | March 12, 2025View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a BuyBYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?By Jeffrey Neal Johnson | March 21, 2025View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?3 Defense Stocks Set to Benefit From Increased Military SpendingBy Chris Markoch | March 20, 2025View 3 Defense Stocks Set to Benefit From Increased Military SpendingResilient Investing: 3 Stocks Built to Weather Market VolatilityBy Jeffrey Neal Johnson | March 17, 2025View Resilient Investing: 3 Stocks Built to Weather Market VolatilityJNJ and ISRG Company DescriptionsIntuitive Surgical NASDAQ:ISRG$494.61 -12.44 (-2.45%) Closing price 04:00 PM EasternExtended Trading$493.05 -1.56 (-0.31%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.Johnson & Johnson NYSE:JNJ$159.90 +4.54 (+2.92%) Closing price 03:59 PM EasternExtended Trading$159.00 -0.89 (-0.56%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom’s VMware Strategy Could Fuel the Next AVGO Rally Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy? Celsius Heats Up: Acquisition, Analyst Upgrade Fuel Momentum 5 Reasons Why Halliburton Is a Good Buy in 2025 First Watch Restaurant Group: A First-Rate Small-Cap Growth Stock Tesla Stock: What To Expect With Their Delivery Numbers Report Rocket Lab: $5.6 Billion Defense Contract Fuels RKLB’s Future Equinix: A Smart Bet on Data Centers, Dividends, and AI Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
